Clinical Trial Update: Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating repeat dosing of GSK159797 in asthmatic patients with chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK159797 (GSK159797)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED